Longevity News

Immorta Bio reports 70% lifespan gain in preclinical study

Source: Longevity Technology • Published: 15 Jun 2026, 16:36

Immorta Bio reports 70% lifespan gain in preclinical study

Longevity research report exploring a novel multi-modal therapeutic approach, inviting curiosity about combination strategies reshaping aging medicine.

Key Takeaways
  • Combined senolytic and stem-cell approach increased lifespan by over 70% in preclinical models
  • Combination yielded greater benefits than either senescent‑cell clearance or regeneration alone
  • Improved liver function, tissue repair, and regenerative biomarkers after treatment
Read Original Source